Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP204044.RASMxBWEkfutfwfXBUFjJLlnpAfD0w3L4RVZ_oeLrD0QQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP204044.RASMxBWEkfutfwfXBUFjJLlnpAfD0w3L4RVZ_oeLrD0QQ130_assertion type Assertion NP204044.RASMxBWEkfutfwfXBUFjJLlnpAfD0w3L4RVZ_oeLrD0QQ130_head.
- NP204044.RASMxBWEkfutfwfXBUFjJLlnpAfD0w3L4RVZ_oeLrD0QQ130_assertion wasGeneratedBy ECO_0000203 NP204044.RASMxBWEkfutfwfXBUFjJLlnpAfD0w3L4RVZ_oeLrD0QQ130_provenance.
- NP204044.RASMxBWEkfutfwfXBUFjJLlnpAfD0w3L4RVZ_oeLrD0QQ130_assertion wasDerivedFrom befree-20140225 NP204044.RASMxBWEkfutfwfXBUFjJLlnpAfD0w3L4RVZ_oeLrD0QQ130_provenance.
- NP204044.RASMxBWEkfutfwfXBUFjJLlnpAfD0w3L4RVZ_oeLrD0QQ130_assertion SIO_000772 17693194 NP204044.RASMxBWEkfutfwfXBUFjJLlnpAfD0w3L4RVZ_oeLrD0QQ130_provenance.
- NP204044.RASMxBWEkfutfwfXBUFjJLlnpAfD0w3L4RVZ_oeLrD0QQ130_assertion evidence source_evidence_literature NP204044.RASMxBWEkfutfwfXBUFjJLlnpAfD0w3L4RVZ_oeLrD0QQ130_provenance.
- NP204044.RASMxBWEkfutfwfXBUFjJLlnpAfD0w3L4RVZ_oeLrD0QQ130_assertion description "[To establish an additional marker for polymerase chain reaction (PCR)-based measurement of minimal residual disease (MRD) detection in acute myeloid leukemia (AML), the expression level of the combined MDS1-EVI1 and EVI1 gene was quantified by real-time reverse transcription PCR (RT-PCR) in four AML cases at initial presentation and as a follow-up marker during anti-leukemic therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP204044.RASMxBWEkfutfwfXBUFjJLlnpAfD0w3L4RVZ_oeLrD0QQ130_provenance.